study question: Is patient screening for emotional risk factors before starting IVF treatment feasible? summary answer: Introduction of screening for emotional risk factors by a validated instrument (SCREENIVF) in couples treated by IVF or ICSI is feasible, indicated by a moderate to high and stable uptake rate, a high acceptance of the process of SCREENIVF, and a high acceptability of the presented risk profile by the patients.
Introduction
Infertility is defined as a disease of the reproductive system resulting in a failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse (Zegers-Hochschild et al., 2009) . Worldwide 72 -80 million people suffer from involuntary childlessness (Nachtigall, 2006; Boivin et al., 2007) . One of the treatment options is IVF; defined as an assisted reproductive technology (ART) procedure that involves extracorporeal fertilization (Zegers-Hochschild et al., 2009) . In 2006 in Europe, 359 110 ART cycles were annually performed among a total population of 422.5 million (de Mouzon et al., 2010) . For IVF, the clinical pregnancy rate was on average 29% and for ICSI it was 30% (de Mouzon et al., 2010) .
Since ARTs such as IVF and ICSI are complex, time-consuming and stressful, they have been the subjects of many studies investigating emotional distress (Schmidt, 2006; Verberg et al., 2008; Brandes et al., 2009; Boivin et al., 2011) . During infertility and fertility treatment, many IVF/ ICSI patients report experiencing minor to severe emotional distress (Verhaak et al., 2005) . Almost 30% of the couples drop out of treatment mainly because of psychological burden (Olivius et al., 2004; Rajkhowa et al., 2006; Brandes et al., 2009; Domar et al., 2010; Boivin et al., 2011) . Six months after their last unsuccessful IVF/ICSI treatment, 20% of women experience such severe anxiety or depression that it interferes with daily life (Verhaak et al., 2005) , indicating that a substantial number suffer from emotional maladjustment, although the majority seems to be able to adjust. Therefore, it is important to identify patients at risk for emotional problems in time, ideally before starting their fertility treatment, which would enable clinicians to offer them additional psychosocial care and to anticipate to this emotional vulnerability in their consultation. This might prevent emotional problems in IVF/ICSI patients, and might be a valuable asset to standard care in fertility treatment (Schmidt, 2006; Verhaak et al., 2010) . Verhaak et al. (2010) developed and validated a short questionnaire consisting of 34 items, which is named SCREENIVF and is aimed at identifying women at risk for emotional maladjustment before the start of their IVF/ICSI treatment. SCREENIVF is based on five previously identified risk factors (Verhaak et al., 2005) : (i) pretreatment anxiety; (ii) pretreatment depression; (iii) helplessness regarding fertility problems; (iv) less acceptance regarding fertility problems and (v) lack of social support. When patients score above the cut-off for clinically relevant problems on one of these risk factors, they were indicated as 'at risk'. Patients at risk were invited to seek additional psychosocial support (Verhaak et al., 2010) . Earlier research investigated to what extent SCREENIVF showed a predictive value for the emotional maladjustment of women. This research found that SCREENIVF identified 34% of the women as at risk at pretreatment with a sensitivity of 69% and a specificity of 77% (Verhaak et al., 2010) .
In September 2009, our tertiary IVF clinic introduced SCREENIVF as a new intervention in daily clinical care. By introducing SCREENIVF, we aimed to facilitate identification of risk groups for emotional maladjustment in time, and to tailor offering of additional psychosocial support to the risk profile of patients. To assess the uptake rate of such a new intervention and to give us the opportunity to optimize its implementation, a process evaluation can be helpful (Hulscher et al., 2003) . A process evaluation consists of the identification of key processes and outcome(s) of an intervention by investigating the actual exposure to the intervention and the experiences of the people exposed (Hulscher et al., 2003) . A subsequent step is the identification of mechanisms by which the intervention will lead to improved outcome and the identification of barriers and facilitators for application. Finally, these results can give insight into the best achievable implementation strategy to improve daily use of this intervention (Campbell et al., 2007) .
Therefore in this study, we aimed to evaluate the introduction of SCREENIVF by assessing its uptake rate, and by performing a process evaluation of the administration itself and the results of SCREENIVF. Based on these results, we aim to suggest improvement mechanisms by overcoming barriers and using facilitators for implementation.
Materials and Methods

Study design
In this prospective cohort study, we used three ways of collecting data to evaluate the implementation of SCREENIVF.
Uptake rate
We analysed the uptake rate of SCREENIVF in a first cohort of patients who started their IVF treatment a few months after introducing SCREEN-IVF (cohort 1). To assess the stability of the uptake rate, SCREENIVF was administrated in a second cohort a year later (cohort 2).
Non-responders (cohort 1)
We analysed the characteristics of the non-responders and their reasons for non-response.
Process evaluation (cohort 1)
For the first cohort, we performed a process evaluation. In this process evaluation, we described patients' characteristics, how patients evaluate the administration, the results of SCREENIVF and the actions patients undertook following the results of SCREENIVF.
SCREENIVF
For details of the content of SCREENIVF, we refer to Verhaak et al. (2010) . SCREENIVF is a short questionnaire consisting of 34 items aimed at identifying women at risk for emotional maladjustment before the start of their IVF/ICSI treatment. The SCREENIVF questionnaire consists of 10 items assessing state anxiety based on a short version of Spielberger State and Trait Anxiety Inventory (Spielberger, 1983) ; 7 items assessing depression based on the short Beck depression Inventory (Beck et al., 1997) , 6 items assessing helplessness and 6 items assessing lack of acceptance, both from the Illness Cognition Questionnaire for IVF patients (Evers et al., 2001; Verhaak et al., 2005) ; and 5 items assessing perceived social support derived from the Inventory of Social Involvement (Van Dam-Baggen and Kraaimaat, 1992). Use of SCREENIVF results in an at risk score when the score on one of the five risk factors shows clinically relevant problems. The cut-off of the depression scale is four or higher. The cut-off for the short version of the STAI was based on scores of 1 SD above the mean in a Dutch norm group consisting of women: score 24 and above. The cut-off scores for the scores of helplessness, acceptance and social support are 14 and above for helplessness, 11 and less for acceptance and 15 and less for social support (based on 1 SD above or below the mean scores of IVF patients in a previous study; Verhaak et al., 2010) .
Setting and participants
This study was performed at a university hospital (Radboud University Nijmegen Medical Centre) in a medium-sized city in the Netherlands. SCREEN-IVF was implemented in daily care from September 2009. In the first cohort, we included all patients (male and female) who started their first IVF/ICSI cycle between 1 December 2009 and 28 February 2010 in our tertiary IVF clinic (n ¼ 304). In the second cohort, we included all patients who started their first IVF/ICSI cycle between 1 November 2010 and 31 January 2011 (n ¼ 342). Figure 1 shows a timeline to illustrate the chronology. All patients were eligible when they had an indication for IVF or ICSI treatment according to the IVF guideline formulated by the Dutch Society for Obstetrics and Gynaecology (NVOG, IVF guideline, www.nvog.nl), and were about to start their first cycle of a new IVF or ICSI treatment. This means that patients had not had any IVF/ICSI treatment before, or that they were about to start a new IVF/ICSI treatment after achieving a successful pregnancy.
As part of their daily care, all patients received the SCREENIVF questionnaire with an introduction letter by mail between 1 and 3 months before the start of their IVF/ICSI treatment. In this introduction letter, patients were asked to complete SCREENIVF for clinical purposes. After returning the completed questionnaire, they received their results by mail, and patients at risk were sent an additional letter to offer them psychosocial care.
In the Netherlands, IVF and ICSI are performed in 13 licensed hospitals. Hospitals without a licence can initiate and monitor the stimulation phase then refer to a licensed hospital for both oocyte retrieval and embryo transfer (satellite clinics) or for embryo transfer alone (transport clinics). The costs of the first three fresh IVF or ICSI cycles are currently reimbursed by the national healthcare system. In 2010, a total of 16 898 IVF and ICSI cycles were performed (Smeenk and Kremer, 2011) .
Outcome measures
Uptake rate
We assessed the uptake rate and the percentage of patients at risk for emotional maladjustment according to SCREENIVF in both cohorts, separated by gender. The uptake rate was determined as the percentage of patients who returned SCREENIVF of the total of patients who were sent SCREENIVF (i.e. all patients on the IVF waiting list).
Non-responders (cohort 1)
Among the non-responders, we assessed what their reasons for nonresponse were and what the differences in background characteristics were between patients responding and not responding to SCREENIVF.
Process evaluation (cohort 1)
For the first cohort, we performed a process evaluation. We assessed how patients evaluated the administration of SCREENIVF and the results they received, in terms of readability, recognition of the outcome and perceived usefulness of the results. In addition, we described the actions patients undertook after getting the results of the SCREENIVF questionnaire, who contacted a psychosocial counsellor, and which barriers they experienced when seeking psychosocial help.
Data collection
Uptake rate
The uptake rate of SCREENIVF was assessed as the response rate to the screening questionnaire by analysing the SCREENIVF database where the results of the screening were collected, and comparing this with the list of patients who were sent SCREENIVF. All patients, both partners, who were placed on the IVF waiting list were sent a SCREENIVF questionnaire. All patients were part of a couple, because single parenthood is not supported in our clinic. We assessed the at-risk rate according to the cut-off levels defined by Verhaak et al. (2010) . Patients who did not send back SCREENIVF were considered as the non-responders. In the second cohort, a year later, we re-assessed the uptake rate and percentage at risk to evaluate if this uptake rate was stable after the introduction of SCREENIVF in daily clinical practice in September 2009.
Non-responders (cohort 1)
Among the non-responders, we performed a telephone survey, in which we investigated the same background characteristics as well as the reasons for not returning the screening questionnaire. This was a standardized questionnaire performed by one interviewer.
Process evaluation (cohort 1)
Finally, we performed a process evaluation in May 2010 by sending a process evaluation questionnaire to all patients who returned SCREENIVF before 30 April 2010. This questionnaire was divided into three parts. First, we measured demographic factors, such as ethnic background, religion and educational level. In this part, we also measured fertility-related background characteristics, such as indication for IVF/ICSI, duration of fertility problems and if they had had a previous child or not. Subsequently, we evaluated patients' experiences with the counselling performed by their clinician and their cognitions with respect to usefulness, readability and user friendliness of SCREENIVF. Examples of questions were: 'The language used in the SCREENIVF questionnaire was. . . (very easy; easy; normal; hard; very Figure 1 Timeline of the study.
Screening for emotional risk factors before IVF hard)' or 'the instruction for SCREENIVF was. . . (very clear; clear; a bit clear; unclear; very unclear)'. Finally, we asked a number of questions about attitude towards psychosocial help and help seeking behaviour, for examples see Table VI . Items were scored on a five-point Likert scale (from 1 ¼ very often indeed to 5 ¼ not at all). Using this five-level scale gives a positive or negative response to a statement, with the possibility to give nuances and without forcing people to make a choice. For the analysis, we combined the upper two (¼agree) and lower two (¼disagree), and coded the middle answer as neutral (Norman, 2010) .
Analysis
We analysed the data using SPSS 16.0 and performed descriptive statistics, t-tests, parametric and non-parametric tests, x 2 test, McNemar tests and
Fisher's exact test where appropriate. A P-value lower than 0.05 was determined as statistically significant.
Results
Uptake rate
The uptake rate of SCREENIVF in cohort 1 between 1 December 2009 and 28 February 2010 was 78% (236 out of 304 patients returned the completed screening questionnaire), and 78 responders were found to be at risk [33%, 95% confidence interval (CI): 27-39%].
In cohort 2, a year later, the uptake rate was 80% (274 out of 342 patients returned the screening questionnaire), and 81 of the responders were at risk for emotional maladjustment (30%, 95% CI: 24 -35%). The uptake, the risk rates and the sub scores of SCREENIVF for cohort 1 can be found in Fig. 2 . Comparing both cohorts, there were no differences in the uptake rate and at-risk rate for men and women. In the total group (cohort 1 and cohort 2) as well as in both cohorts separately more female than male were at risk (chisquare for total group 17.6, P , 0.001; for cohort 1 chi-square 4.9, P , 0.03; for cohort 2 chi-square 12.8, P , 0.001). The differences in the results of SCREENIVF between cohort 1 and cohort 2, and separated by gender can be found in Table I .
Non-responders (cohort 1)
The response rate of the telephone survey among non-responders was 40% (27 patients out of 68 non-responders), 41% of whom explained their non-response by claiming there was no actual need for psychological help, while 19% forgot to complete the screening (Table II) . We compared the background characteristics of the 91 responders (out of 210) who answered the process evaluation questionnaire with the 27 non-responders of SCREENIVF (out of 68) who answered the telephonic review. Compared with responders, non-responders significantly more often had had an IVF treatment in a previous period (41 versus 21%, P , 0.05), had a non-Dutch ethnic background (26 versus 9%, P , 0.05), were Muslim (15 versus 4%, P ¼ 0.05) or had no religion (54 versus 30%, P , 0.05) and were less likely to be Christian (31 versus 61%, P , 0.05) There was a significant difference between cohort 1 and cohort 2 on the % patients at risk (chi-square test).
( Table III) . Responders were more likely to be childless than nonresponders (69 versus 44%, P , 0.05).
Process evaluation (cohort 1)
Patients' characteristics
The process evaluation questionnaire was sent to 210 people who had responded to SCREENIVF. There were 26 patients who were not eligible for the process evaluation because they sent the SCREENIVF questionnaire back after our mailing of the process evaluation questionnaire. Of the 210 patients, 43 completed the process evaluation questionnaire (n ¼ 91). Comparing the patients' characteristics between those who were and were not at risk, we only found that patients with a non-Dutch ethnic background (21 versus 5%, P , 0.05), especially those who had indicated they had a Muslim religion (17 versus 0%, P , 0.05), were significantly more at risk for emotional maladjustment (Table IV) .
Evaluation of SCREENIVF questionnaire
Most people (90%) thought that the screening was useful. Even more people (95%) reported that filling in SCREENIVF was not unpleasant. The mean time needed to fill in SCREENIVF was 10 min and 40 s, which most patients thought was not too long. The results concerning their experiences can be found in Table V . A large proportion of the patients reported that the result of the screening was not explained (68%) to them by their medical clinician. Almost all patients (93%) agreed with the results of the screening, the four people who did not were all found to be at risk. T-tests for independent samples showed no differences between men and women regarding the answers to these questions (t values not presented).
Action of patients
We assessed barriers for seeking psychological help in all patients, at risk and not at risk (Tables VI and VII 
Discussion
In this study, it is shown that the introduction of a validated screening questionnaire for emotional maladjustment, performed in women before the start of their first IVF treatment, in daily care is feasible. Also in men, for whom SCREENIVF is not completely validated yet, administration before start of the IVF treatment was feasible. Using SCREENIVF can help to identify patients at risk for emotional maladjustment in time to enable clinicians to offer additional psychosocial support. In addition, SCREENIVF provides patient feedback on their psychosocial risk profile, enabling them to become more aware of their maladjustment. This is one of the few studies reporting the implementation of a psychosocial intervention integrated in daily clinical practice. The response rate of SCREENIVF was around 78 -80%, which is satisfactory. A screening instrument in cancer patients, the distress thermometer, had an uptake rate of 50% (Tuinman et al., 2008) . We found that one-third of the patients who filled in SCREENIVF are at risk for emotional maladjustment. This percentage is comparable with the results described by Verhaak et al. (2010) earlier. Analysis of sub-scores of the risk profile of the patients of cohort 1 and cohort 2 showed significant differences in scores on anxiety and depression. However, the total percentage of patients at risk in the two cohorts was not statistically different, in both cohorts, one-third of the patients. To explain these statistical differences in sub-scores, we have to focus on differences in background variables and drop out rates between the cohorts, but this was beyond the focus of this implementation study.
The most frequent reasons for non-response to SCREENIVF were 'I have no need for psychological help' and 'I forgot'. We expect to improve the response rate by offering better counselling about the aim of the SCREENIVF questionnaire by the physician and nurses, by improving our information sheet, and by sending reminders. Additional suggestions to facilitate the administration of the questionnaire are using the Internet and offering SCREENIVF in different languages. e Parametric t-test shows in this item significant difference between male and female; females planned significantly more often to seek professional psychosocial help.
f Three patients (12.5%) already received psychosocial help.
Our results show that according to SCREENIVF, patients with a non-Dutch ethnic background and/or a Muslim religious background are more vulnerable to psychosocial problems. Whether this is due to the content of SCREENIVF or to the cultural and religious background of this specific patient group is unclear. SCREENIVF was developed and validated in a Dutch cohort of subfertile patients; their background characteristics were not collected in the validation phase of SCREENIVF (Verhaak et al., 2010) . Cultural and religious differences in cognitions about child wishes, parenthood and subfertility might explain the difference observed (Husain, 2000) . In Islam, to have children is seen as a great blessing (Husain, 2000) . Depending on the interpretation of the Qur'an, motherhood is believed to be the most important role for women and the perceived essence of women's identity in Islamic culture (Husain, 2000) . This might explain the higher SCREENIVF at risk scores in patients with a non-Dutch ethnic background and patients with a Muslim religion.
The process evaluation questionnaire showed that the majority of patients screened as at risk for emotional maladjustment, but did not seek professional help. Only 5 of the 24 patients found to be at risk (21%) said they were planning to seek professional help. It is known that infertility patients rely primarily on their partner and family when distressed, rather than on formal support such as psychosocial counselling (Boivin et al., 1999) . In our study, we found that travelling distance can be a barrier for seeking professional help. According to Boivin et al. (1999) more distressed patients fail to initiate contact with a counsellor because of practical concerns, and the focus should be on alternative ways of intervening with infertile people.
Psychosocial care offered by Internet seems promising in lowering the threshold for psychosocial help by meeting the barriers of work or travelling distance (Sexton et al., 2010) . Sexton et al. evaluated the efficacy of a web-based approach to providing a cognitive behavioural intervention. There was a significant decline in general stress, but no significant improvement of infertility-specific stress. In addition, in 2010, Haemmerli et al. (2010) evaluated an internet-based support tool for infertile patients. This intervention showed a significant reduction in the depression level of clinically distressed and depressed infertile patients. The treatment was positively evaluated by the patients. Based on this, Internet-based interventions seem promising in supporting infertile patients especially patients suffering from clinical relevant levels of distress and depression. This is in line with the recent discussion about practical interventions to reduce fertility-related burdens to focus on the risk groups of patients and to adjust interventions to the patient's risk profile (Boivin et al., 2012) . Further research is necessary to find out how to realize a better fit between psychosocial vulnerability of patients and the availability of additional support, in terms of screening, tailored care and counselling.
Unfortunately, because of the low response rate of the process evaluation questionnaire, differences in the results of the process evaluation between men and women could only be interpreted cautiously.
SCREENIVF was developed and validated in women to identify emotional maladjustment before the start of the IVF/ICSI treatment. We administered SCREENIVF in men too, in order to be able to also address the question of feasibility in men. Regarding the validation of SCREENIVF, which was not the focus of this study, we could say that SCREENIVF consists of five subscales that are individually validated for men as well as women (Spielberger, 1983; Van Dam-Baggen and Kraaimaat, 1992; Beck et al., 1997; Evers et al., 2001; Verhaak et al., 2005) . The men identified as 'at risk' on SCREENIVF showed relevant problems on the different subscales, indicating psychosocial vulnerability. However, to date, in men before the IVF/ICSI treatment, there is no validation for the total at risk score on SCREENIVF. This needs to be addressed in a future study. From the literature, it is clear that men and women react differently to the diagnosis and treatment of infertility (Wischmann et al., 2009) . Also the degree of emotional distress can be different. The psychological distress on the part of the women seems to be the strongest factor in the decision to seek psychological help (Wischmann et al., 2009 Parametric t-test shows in this item a trend towards difference between male and female; males more often thought they would benefit from psychosocial help.
d
Parametric t-test shows in these items significant difference between male and female; females experienced their job significantly more often as an obstacle than males, and females planned significantly more often to seek professional psychosocial help.
e Two patients (3.0%) already received psychosocial help.
Screening for emotional risk factors before IVF provide information about how to design psychosocial care to the different needs of men and women. Another limitation of the study is the low response rate of the process evaluation questionnaire, 43%. Therefore, we do not know for example what the help-seeking behaviour of the 119 non-responders to the process evaluation questionnaire is. Despite this response rate, we were able to evaluate our screening instrument and to make suggestions for improvement. We did not take the results of the IVF treatment into account; there can be a bias when people who did achieve a pregnancy were more eligible to return the process evaluation questionnaire, and the results of the IVF treatment could have influenced their answers. On the contrary, patients who did not achieve a pregnancy could have been more vulnerable for emotional maladjustment and could have been more willing to fill in the process evaluation questionnaire. The pregnancy rate after treatment should be taken into account in future studies. Also, we were not able to evaluate all responders due to practical reasons. Furthermore, SCREENIVF was only available in Dutch and it is possible that non-Dutch patients did not fill in SCREENIVF. Therefore, a selection bias cannot be excluded. We do not know what the size of this group is or what percentage of these patients would have been at risk for emotional maladjustment. We do not expect this group to be very large and influencing our results, because most patients eligible for IVF treatment understand the Dutch language. By offering SCREENIVF in other languages; however, we aim to respond to this selection bias in future. Finally, we performed the screening in only one Dutch centre. We do not know what the international application of this screening instrument will be; neither do we know how the introduction of SCREENIVF in another Dutch centre will go. Our centre offers various fertility treatments in a large general population. Therefore, we expect the results to be similar in other Dutch, or European, centres. One of the aims of the implementation of SCREENIVF was also to provide health care professionals with information about the risk profile of the patients. This enables them to tailor their interventions to the vulnerability of the patients. Highly distressed patients could be advised more strongly to seek additional support. In daily care, the clinician could be more aware of the patient and their vulnerability, which enables them to tailor care. Future research has to point out how physicians evaluate the use of a psychosocial screening instrument such as SCREENIVF and how they use the results of the screening in their daily clinical practice.
One strong aspect of this study is the evaluation of the integration process of a screening instrument within daily clinical care. Also, the availability of data of a large group of screened patients, both men and women, makes it possible to evaluate the long-term effects of screening.
In summary, this study showed the process evaluation of the introduction of screening patients for emotional risk factors, and concluded that it is feasible. Considering the actions of the patients, travelling distance can be a barrier for patients seeking psychological help. Further research is needed to investigate if psychosocial care offered by the Internet can meet this barrier of travelling distance and diminish symptoms of distress or depression. Internet-based interventions should be compared with regular care and vis-a-vis psychosocial therapy to prove the effect and to show if these interventions can replace or serve as a supplement to usual care. Further research should be focused on barriers and facilitators for help-seeking behaviour taking differences between ethnic groups and men and women into account. This would increase the possibility of tailoring interventions to the needs of the individual patients, and their risk profile, their cultural background and their gender.
